Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J.P. Morgan Day Three: Biogen Still Shopping For Deals, Sanofi Explains Its View On Oncology

11 Jan 2024

• By Scrip Team

J.P. Morgan 2024 — • Source: Shutterstock

Related Content

Sanofi Falls Further Behind In Cancer

21 Dec 2023

Biogen Buys Time For Leqembi Ramp-Up With Reata Acquisition

28 Jul 2023

Takeda Will Take TYK2 Inhibitor Into Phase III, Looks For Dosing Edge Over BMS Rival

08 Nov 2023

Sage Readies Zurzuvae For December Launch With Slow Ramp As Payer Talks Progress

08 Nov 2023

Sanofi Picks Venture Capitalist Ashrafian To Succeed Reed As R&D Head

31 Aug 2023

Related Companies

Biogen, Inc.

Reata Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Sanofi

Takeda Pharmaceutical Co. Ltd.

Nimbus Therapeutics, Inc.

Bristol Myers Squibb Company

Sage Therapeutics, Inc.

Additional Topics

Business Strategies Deals Launches Commercial BioPharmaceutical

More from Strategy

More from Conferences

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.